-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs lifts Carl Zeiss Meditec voting rights to 5.27% via instruments

PUBT·09/02/2026 11:23:10
Listen to the news
Goldman Sachs lifts Carl Zeiss Meditec voting rights to 5.27% via instruments
  • Goldman Sachs built a 5.27% total stake in Carl Zeiss Meditec, up from no previously disclosed position.
  • Equity voting rights stood at 0.72%, representing 648,368 shares.
  • Voting rights via instruments reached 4.55%, lifting the combined holding above the 5% threshold.
  • The threshold was crossed on Aug. 25, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carl Zeiss Meditec AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2392724_en) on September 02, 2026, and is solely responsible for the information contained therein.